Page 64 - 2020Taiwan Food and Drug Administration Annual Report

II. Reporting situation of approved institutions for drug abuse urine tests
As of the end of 2019, 4 approved institutions for drug abuse urine tests had been allowed
in testing cathinone group. Moreover, 6 approved institutions and 1 health bureau had been
approved for testing the 4-methylmethcathinone, Nimetazepam and Nitrazepam which were
detected frequently, hence expanding the capabilities in urine testing of illegal drugs, in order to
effectively share the inspection workload of government’s laboratories.
In 2019, there was a total of 231,928 urine tests performed throughout Taiwan, among
them, 59,727 were positive, and the positive rate was 25.8%. The headcount of positive cases for
¿UVW WKUHH W\SHV RI GUXJV DEXVHG ZDV PHWK DPSKHWDPLQH NHWDPLQH DQG PRUSKLQH &RPSDULQJ
with the data of urine tests in 2018, the case number of methamphetamine, ketamine, and

morphine were decreased by 59.2%, 6.1%, and 35.5% respectively.

,,, 5HSRUWLQJ VLWXDWLRQ RI GUXJ DEXVH QRQ XULQH 'UXJ WHVWV
In 2019, there was a total of 157,077 cases with positive test results in non-urine specimens
of suspicious drug and controlled drug cases in Taiwan, of which 22,681 were methamphetamine
cases, 18,291 were ketamine cases, and 20,172 were heroin cases. Comparing to the data in
2018, the numbers of cases with positive test results in non-urine tests of methamphetamine,
ketamine, and heroin were all decreased, and the largest reduction was methamphetamine cases,
24.9%.

62